BioRestorative Therapies announced the filing of a registration statement on Form S-1 with the SEC. The registration statement solely covers the resale by selling securityholders of up to 2,513,686 shares of common stock of the company that are issuable pursuant to the exercise of previously issued warrants. The filing was made pursuant to registration rights granted to the selling securityholders in connection with the issuance of the warrants to them.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRTX:
- BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K
- BioRestorative Therapies Clarifies Disclosure Regulations Impact
- BioRestorative Therapies to Participate in the 36th Annual ROTH Conference
- BioRestorative Therapies Sparks Investor Interest with New Transaction
- BioRestorative Therapies Secures $8.1M Through Warrant Restructuring